Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Leukemia|January 27, 2022
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myelomaSophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2020
Aneuploidy increases resistance to chemotherapeutics by antagonizing cell divisionJohn Michael Replogle, Wen Zhou, Adrianna E Amaro, et al.
Science Advances|June 23, 2023
Sequential apoptotic and multiplexed proteomic evaluation of single cancer cellsEmmalyn Lecky, Atreyi Mukherji, Rebecca German, et al.
Developmental Cell|May 30, 2014
APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destructionLixin Wan, Mingjia Tan, Jie Yang, et al.
Blood Advances|February 10, 2023
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemiaElyse A Olesinski, Karanpreet S Bhatia, Aarthi N Mahesh, et al.
Cell Reports|December 24, 2016
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic ResistanceJessie Pécot, Laurent Maillet, Janic Le Pen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
TP53 mutations drive therapy resistance via post-mitochondrial caspase blockadeAhmed M Mamdouh, Elyse A Olesinski, Fang Qi Lim, et al.
Cancer Research|March 29, 2014
Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancersAaron N Hata, Alan Yeo, Anthony C Faber, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Leukemia|January 27, 2022
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myelomaSophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2020
Aneuploidy increases resistance to chemotherapeutics by antagonizing cell divisionJohn Michael Replogle, Wen Zhou, Adrianna E Amaro, et al.
Science Advances|June 23, 2023
Sequential apoptotic and multiplexed proteomic evaluation of single cancer cellsEmmalyn Lecky, Atreyi Mukherji, Rebecca German, et al.
Developmental Cell|May 30, 2014
APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destructionLixin Wan, Mingjia Tan, Jie Yang, et al.
Blood Advances|February 10, 2023
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemiaElyse A Olesinski, Karanpreet S Bhatia, Aarthi N Mahesh, et al.
Cell Reports|December 24, 2016
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic ResistanceJessie Pécot, Laurent Maillet, Janic Le Pen, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
TP53 mutations drive therapy resistance via post-mitochondrial caspase blockadeAhmed M Mamdouh, Elyse A Olesinski, Fang Qi Lim, et al.
Cancer Research|March 29, 2014
Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancersAaron N Hata, Alan Yeo, Anthony C Faber, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Pageof 19